FOLD vs LEN · rev $528.3M vs rev $34.19B
Amicus Therapeutics Inc (FOLD) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
LEN (LEN) common stock.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
FOLD currently screens at market cap $1.80B. LEN currently screens at market cap $0.
Not investment advice. Open the FOLD and LEN stock pages for the full models.
Not investment advice.